Categories: News

OsteoCentric Technologies Announces Formation of UnifiMI Industrial Companies

AUSTIN, Texas, May 1, 2025 /PRNewswire/ — OsteoCentric Technologies, a global leader in innovative fastener technologies, announced the creation of seven wholly-owned subsidiaries dedicated to penetrating key industrial market segments including Aerospace & Defense, Transportation, Construction, Oil & Gas, Automotive, Agriculture, and Sporting Goods. This strategic move leverages the company’s proprietary UnifiMI® Fastener Technology to address some of the most critical challenges, across the most demanding industrial applications.

“Our invention of the UnifiMI implant-to-bone interface, the world’s first Minimally Invasive Surgery (MIS) Bone Preservation technology, disrupted the medical device industry by accelerating the healing journey for orthopedic and dental patients. Our industrial team, led by Nick Medendorp, will leverage ten years of development and $200M investment in UnifiMI medical applications to address fixation problems across the entire industrial complex,” said Eric Brown, Founder and CEO of OsteoCentric Technologies & UnifiMI Industrial Companies.

UnifiMI Industrial Companies aim to deliver high-quality, high-performance, customizable fastening solutions by utilizing advanced techniques and fostering collaborative partnerships with industry leaders. UnifiMI® Fastener Technology represents a paradigm shift in fastening solutions designed to address critical application challenges such as vibrational loosening, material preservation, and stress management.

“Combined with our comprehensive experience, principles of substrate preservation, and our patented interlocking thread form, UnifiMI is well positioned for continued optimization. By extending our proven UnifiMI® Fastener Technology into industrial market segments and tailoring for widescale applications, we are poised to offer innovative solutions that allow for lasting mechanical integration, energy management and load-sharing stress distribution, while ensuring safety, reliability, and performance,” said Nick Medendorp, President UnifiMI Industrial Companies.

For more information about the UnifiMI industrial companies and their innovative fastening solutions, please visit www.unifimi.com.

About UnifiMI Industrial Companies
Founded in 2024, with global headquarters in Austin, Texas and development center in Logan, Utah, UnifiMI Industrial is dedicated to understanding the unique needs of its customers and markets. Active collaboration with customers, suppliers, and employees is central to UnifiMI Industrial’s approach, ensuring added value and optimal outcomes for all stakeholders.

View original content to download multimedia:https://www.prnewswire.com/news-releases/osteocentric-technologies-announces-formation-of-unifimi-industrial-companies-302442900.html

SOURCE OsteoCentric Technologies

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

23 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

23 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

23 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

23 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

23 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

23 hours ago